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A case of post-transplantation pneumonia due to Candida krusei is reported. A 42-year-old
man was admitted 28 days after heart transplantation with cough, pleuritic pain and
fever. A chest computed tomograph showed multiple alveolar infiltrates bilaterally. He
received broad-spectrum antibiotics, fluconazole for oral candidiasis, and cotrimoxazole
for possible Pneumocystis carinii. A short-lived period of improvement was followed by
respiratory failure. Cultures of bronchial washings grew C. krusei and C. albicans. The
infection was documented by histology and culture obtained by transthoracic aspiration.
Treatment with amphotericin B was initiated, but the patient died. Histology and culture
of a pulmonary specimen, obtained immediately post mortem, further documented the
infection with C. krusei.
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Pneumonia due to Candida is a serious infection,
predominantly affecting immunocompromised or
debilitated patients, often with fatal outcome. Can-
dida albicans is the species usually isolated from
such cases, whereas non-albicans Candida (such as
C. glabrata) rarely cause pneumonia and occur
almost exclusively in immunocompromised pa-
tients. We report here a post-heart-transplantat
case of pneumonia, from the lung biopsy of which
we isolated Candida krusei, which we believe to be
the first such case published in English.
A 42-year-old man with a heart transplant was
admitted to our hospital because of malaise, cough
and pleuritic chest pain of 48 hours' duration. In
the previous 12 h he had also developed fever up
to 39°C.
The patient had undergone heart transplanta-
tion 28 days prior to this admission, for cardiac
failure due to myocardiopathy. Preoperative
work-up had yielded the following data: Mantoux
test negative, serum HbsAg and antibodies to
human immunodeficiency virus (HIV) negative,
cytomegalovirus (CMV) antibody titre 1: 160 for
immunoglobulin G and 1 :40 for immunoglobulin
M. The donor had been negative for all of the
above tests.
Four days after transplantation the patient
developed nosocomial pneumonia, from which
he recovered when treated with empirical broad-
spectrum antibiotic treatment. He was on cyclos-
porine, azathioprine and methylprednisolone for
immunosuppression and intravenous gancyclovir
for prophylaxis against CMV infection. His past
medical history was remarkable only for hyperten-
sion discovered five years earlier. He was a truck
driver, married and father of six healthy children.
He had smoked 50 cigarettes per day since the age
of 18 years. He had never used illicit drugs.
On admission he appeared ill, but well nour-
ished. He had peripheral cyanosis and oral thrush.
He was slightly tachypnoeic (26 respirations/
min), with a temperature of 38°C, a heart rate of
90 beats/min and blood pressure of 95/60mmHg.
On auscultation, rales at the left lower and right
middle and upper pulmonary fields were appar-
ent. Otherwise, his physical examination was
unremarkable.
Laboratory examination revealed hemoglobin,
10.5g/dL; hematocrit, 31.7%; platelets, 87000/IlL;
white blood cells, 2700/ilL (94% neutrophils,
4% lymphocytes, 2% monocytes); creatinine,
1.2 mg/dL; bilirubin, 4.3 mg/dL (direct 2.6 mg/dL,
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Figure 1 Chest CT scan obtained on
the 2nd day of hospitalization at an
anatomic level that shows two of the
several alveolar infiltrates.
indirect 1.7 mg/dL); alkaline phosphatase, 269 lUlL
(normal 80-200); alanine aminotransferase (ALT),
75 IUIL; aspartic aminotransferase (AST), 31 IUI
L; y-glutamyl transpeptidase (GT), 72 lUlL; lactate
dehydrogenase, 307 IUIL; prothrombin time 12 s I
14.4 s (57%); activated partial thromboplastin time
37 s; fibrinogen, 270 mgldL; and total serum pro-
tein, 6.0 gldL (albumin 3.0 gldL, globulin 3.0 gl
dL). All other hematological and biochemical
parameters were normal. Blood gases were pH
7.549, P02 65.9mmHg, PC02 26.4mmHg, 02sat
95.4%. A chest radiograph showed multiple areas
of consolidation and computerized tomography of
the chest showed multiple foci of alveolar infil-
trates in both lungs (Figure 1). The electrocardio-
gram and echocardiogram were without signif-
icant findings. The cyclosporine serum level was
266 ng/mL. A Mantoux test was negative. Serol-
ogy was also negative, including antibodies
against Mycoplasma pneumoniae, Toxoplasma gondii,
Epstein-Barr virus, CMV, herpes simplex virus
and HIV. Detection of serum Aspergillus, Candida
and Cryptococcus antigens was negative. A mouth
swab culture yielded C. albicans. Urinalysis and
urine culture were negative. All blood cultures
were negative (four cultures taken during the first
two days and one culture for fungi with 'isolator'
was taken on the tenth day).
Initially the patient was placed on a broad-spec-
trum antibiotic regimen (cefepime, amikacin, van-
comycin); ganciclovir was discontinued. He was
started on granulocyte colony-stimulating factor
for leukopenia and fluconazole (100 mg per day)
for oral candidiasis. He was transiently stabilized,
but three days later he started to deteriorate and
became hypoxaemic. On the fifth day of hospita-
lization trimethoprim-sulphamethoxazole was
added (at 15 mg/kg of trimethoprim per day)
for coverage against Pneumocystis carinii and
Nocardia species. A short-lived period of improve-
ment was followed by a relapse of respiratory
failure. A bronchial lavage was performed on
the tenth day and the cultures of bronchial wash-
ings grew both C. krusei and C. albicans. In addition
to culture, other microbiological tests were carried
out with the material obtained by bronchoscopy,
such as direct microscopic examination of the films
prepared and stained (i) by Ziehl-Nielssen stain
for mycobacteria, (ii) by direct immunofluores-
cence method for P. carinii, and (iii) for detection
of inclusions for CMV. These tests were all nega-
tive.
On the 11th day of hospitalization fluconazole
was discontinued and treatment with liposomal
amphotericin was started (at 1 mg/kg per day). At
that time the imaging studies showed disappear-
ance of several of the pulmonary infiltrates, but
persistence and enlargement of two pre-existing
infiltrates, one on the right middle and one on the
left lower pulmonary field (Figure 2). Repeat blood
cultures were negative. Two days later the patient
developed left hemiplegia and a CT scan of the
head revealed a right-sided hypodense lesion. A
CT-guided transthoracic needle aspiration was
performed on the right middle pulmonary field
lesion. Histology of the aspirate revealed fungal
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Figure 2 Chest CT scan on the 11th
day of hospitalization at an ana-
tomic level that shows one of the
two persistent lesions (the one at the
right middle pulmonary field).
pseudohyphae and C. krusei was grown on Sabour-
aud glucose agar.
Identification of the fungal isolates was per-
formed according to (i) morphological character-
istics from unstained and Gram-stained smears;
(ii) colony morphology on Sabouraud glucose agar
plates; (iii) the germ tube test; and (iv) biochemical
characteristics using the commercial identification
system ID32C system (bioMerieux, Marcy l'Etoile,
France). Susceptibility testing was performed
using the broth microdilution system 'Yeast one'
sensititre (AccuMed International Limited, East
Grinstead, West Sussex, UK). C. parapsilosis ATCC
90018 was also tested as a sensitive control. Both
isolates (from bronchial washings and from trans-
thoracic aspiration) were found to be sensitive to
amphotericin B, 5-flucytocine and ketoconazole,
but resistant to fluconazole.
Treatment with liposomal amphotericin B was
continued. The patient died on the 17th day of
hospitalization, 45 days after heart transplanta-
tion, having received amphotericin B for six days.
Immediately post mortem a lung specimen was
obtained from the area corresponding to the right
middle pulmonary field lesion through a small
thoracic incision under aseptic conditions. Histol-
ogy of the specimen showed fungal pseudohyphae
and the culture grew C. krusei.
A significant change in the epidemiology of
candida1 infections has been noted in the last
decade. There is a reduction in the number of C.
albicans isolates and an increase in the rates of
colonization and infection with non-albicans Can-
dida species, such as C. glabrata and C. krusei [1,2].
This may be due, in part, to changes in antifungal
drug usage in many institutions, such as the
increase in the prophylactic use of fluconazole in
immunocompromised patients [3-6].
Although the majority of fungal infections in the
early post-transplantation period (three months) is
due to Candida species, fungal pneumonia in heart-
transplant recipients is more often caused by
Aspergillus species [7,8]. In these patients, the most
frequent form of invasive candidiasis is sepsis
related to vascular access devices and drainage
catheters, whereas candidal pneumonia is extre-
mely rare [7-9]. This case is interesting not only as
an infection caused by a non-albicans Candida spe-
cies, but also because, to our knowledge, it is the
first case of documented pneumonia due to C.
krusei in the English literature. Other types of
infection with C. krusei have been reported, such
as arthritis, endophthalmitis, and intra-abdominal
abscess, all as a result of fungemia [10-12].
Pulmonary infection due to C. krusei in this
patient was initially suspected by culture of
bronchoalveolar washings. However, bronchoal-
veolar lavage fluid cultures are considered unreli-
able for the diagnosis of Candida pneumonia. The
infection was subsequently documented by histol-
ogy and culture of a specimen obtained by trans-
thoracic aspiration of a pulmonary lesion. In
addition, the histology and culture of a specimen
surgically excised from the same pulmonary lesion
post mortem grew the same organism. Serological
tests for other organisms were negative, although
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tests for Legionella pneumophila were not per-
formed. Systematic surveillance cultures of the
water supplies of our hospital were negative for
Legionella species [13]. Our patient was not on
prophylaxis for P. carinii before admission, as he
was still in the first month after transplantation. It
is very important that these patients are under
prophylaxis for P. carinii during the first six
months post transplantation, since the incidence
of this infection is increased from the second to the
sixth month [14].
The patient initially showed some clinical
improvement after administration of a broad-spec-
trum antibiotic regimen. At that time imaging
studies showed resolution of some of the pulmon-
ary infiltrates and persistence of only two lesions,
which had increased in size. Probably, the initial
pulmonary infection was mixed, fungal and
microbial, and the antimicrobial compounds cured
only the foci of bacterial pneumonia. Fluconazole
did not suppress the candidal infection when
initially administered for oral thrush at a low dose,
since the isolate is inherently resistant to the drug.
Transplant recipients present with a wide variety
of opportunistic infections. Therefore, diagnostic
tests, including invasive procedures, should be
carried out as early as possible [13,14].
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